In vitro and in vivo studies of mesothelioma

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 142-151

  Pass, Harvey I ^a   Mew, Daphne J Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

asbestos; cytogenetics; growth factors; mesothelioma; oncogenes

Indexed keywords

CANCER GROWTH; CANCER SURVIVAL; CHROMOSOME ABERRATION; DNA DAMAGE; GENE ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KARYOTYPE; MESOTHELIOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE; ANIMAL; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CULTURE; CULTURE MEDIUM; DRUG EFFECT; GENE AMPLIFICATION; GENETICS; MOUSE; NUDE MOUSE; ONCOGENE; PATHOLOGY; PLEURA TUMOR; TRANSPLANTATION; XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

ASBESTOS; CYTOKINE; DNA; GROWTH PROMOTOR; TUMOR PROTEIN;

ANIMALS; ASBESTOS; CHROMOSOME ABERRATIONS; CULTURE MEDIA; CYTOKINES; DNA, NEOPLASM; GENE AMPLIFICATION; GENES, P53; GROWTH SUBSTANCES; HUMANS; MESOTHELIOMA; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; ONCOGENES; PLEURAL NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029679543     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(199607)62:1<142::AID-JCB15>3.3.CO;2-7     Document Type: Review

References (74)

1. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL (1990): Asbestos: Scientific developments and implications for public policy. Science 247:294-301.
2. McDonald JC (1985): Health implications of environmental exposure to asbestos. Environ Health Perspect 62: 319-328.
3. Rom WN, Travis WD, Brody AR (1991): Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 143:408-422.
4. Jaurand M-C (1991): Observations on the carcinogenicity of asbestos fibers. Ann NY Acad Sci 643:258-270.
5. Mossman B, Light W, Wei E (1983): Asbestos: Mechanisms of toxicity and carcinogenicity in the respiratory tract. Ann Rev Pharmacol Toxicol 23:595-615.
6. Walker C, Everitt J, Barrett JC (1992): Possible cellular and molecular mechanisms of asbestos carcinogenicity. Am J Ind Med 21:253-273.
7. Versnel JA, Hoogsteden HC, Hagemeijer A, Bouts MJ, van der Kwast TH, Delahaye M, Schaart G, Ramaekers FCS (1989): Characterization of three human malignant mesothelioma cell lines. Cancer Genet Cytogenet 42:115-128.
8. Versnel MA, Bouts MJ, Hoogsteden HC, van der Kwast TH, Delahaye M, Hagemeijer A (1989): Establishment of human malignant mesothelioma cell lines. Int J Cancer 44:256-260.
9. Hsu S-M, Hsu P-L, Zhao X, Kao-Shan CS, Whang-Peng J (1988): Establishment of human mesothelioma cell lines (MS1,-2) and production of a monoclonal antibody (Anti-MS) with diagnostic and therapeutic potential. Cancer Res 48:5228-5236.
10. Klominek J, Robert K-H, Hjerpe A, Wickström B, Gahrton G (1989): Serum-dependent growth patterns of two, newly established human mesothelioma cell lines. Cancer Res 619:6118-6122.
11. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L, Klockars M, Jantunen K, Gerwin BI, Harris CC, Tuomi T, Vanhala E, Mattson K, Linnainmaa K (1990): Asbestos-related malignant mesothelioma: Growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 11:673-681.
12. Hand AM, Husgafvel-Pursiainen K, Tammilehto L, Mattson K, Linnainmaa K (1991): Malignant mesothelioma: The antiproliferative effect of cytokine combinations on three human mesothelioma cell lines. Cancer Lett 58:205-210.
13. Manning LS, Bowman RV, Darby SB, Robinson BWS (1989): Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells. Am Rev Respir Dis 139:1369-1374.
14. Ke Y, Reddel RR, Gerwin BI, et al. (1989): Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced-mesothelioma. Am J Pathol 134:979-991.
15. Reddel RR, Malan-Shibley L, Gerwin BI, et al. (1989): Tumorigenicity of human mesothelial cellline transfected with EJ-ras oncogene. JNCI 81:945-948.
16. Arnold W, Naundorf H, Wildner GP, Nessen E, Tanneberger S (1979): Biological characterization of a mesothelioma line in nude mice. Arch Geschwulstforsch 49:495-507.
17. Chahinian AP, Beranek JT, Suzuki Y, Bekesi JG, Wisniewski L, Selikoff IJ, Holland JF (1980): Transplantation of human malignant mesothelioma into nude mice. Cancer Res 40:181-185.
18. Chahinian AP, Norton L, Holland JF, Szrajer L, Hart RD (1984): Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma. Cancer Res 44:1688-1692.
19. Reale FR, Griffin TW, Compton JM, Graham S, Townes PL, Bogden A (1987): Characterization of a human malignant mesothelioma cell line (H-MESO-1): A Biphasic solid and ascitic tumor model. Cancer Res 47:3199-3205.
20. Sklarin NT, Chahinian AP, Feuer EJ, Lahman LA, Szrajer L, Holland JF (1988): Augmentation of activity of cis-diamminedichloroplatinum (II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice. Cancer Res 48:64-67.
21. Bowman RV, Whitaker D, Manning LS, Davis MR, Robinson BWS (1991): Interaction between dactinomycin and tumor necrosis factor in mesothelioma. Cancer 67:2495-2500.
22. Griffin TW, Richardson C, Houston LL, LePage D, Bogden A, Raso V (1987): Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Cancer Res 47:4266-4270.
23. Raso V, McGrath J (1989): Cure of experimental human malignant mesothelioma in athymic mice by diphtheria toxin. JNCI 81:622-627.
24. Mohr U, Potts F, Vonnahme F-J (1984): Morphological aspects of mesotheliomas after intratracheal instillations of fibrous dusts in Syrian golden hamsters. Exp Pathol 26:179-183.
25. Suzuki Y, Kohyama M (1984): Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. Environ Res 35:277-292.
26. Wagner JC, Griffiths DM, Hill RJ (1984): The effect of fibre size on the in vivo activity of UICC crocidolite. Br J Cancer 49:453-458.
27. Hill RJ, Edwards RE, Carthew P (1990): Early changes in the pleural mesothelium following intrapleural inoculation of the mineral fibre erionite and the subsequent development of mesotheliomas. J Exp Pathol 71:105-118.
28. Suzuki Y (1991): Comparability of mesothelioma in humans and in experimental animal studies. Ann NY Acad Sci 643:219-222.
29. England JM, Panella MJ, Ewert DL, Halpern MS (1991): Induction of a diffuse mesothelioma in chickens by intraperitoneal inoculation of v-src DNA. Virology 182: 423-429.
30. Carbone M, Cicala C, Pompetti F, Festa A, Levine AS (1992): SV40 induces mesotheliomas in hamsters. Proc Am Assoc Cancer Res 33:393.
31. Appel JD, Fasy TM, Kohtz DS, et al. (1988): Asbestos fibers mediate transformation of monkey cells by exogenous plasmid DNA. Proc Natl Acad Sci USA 85:7670-7674.
32. Gibas Z, Li FP, Antman KH, Bernal S, Stahel R, Sandberg AA (1986): Chromosome changes in malignant mesothelioma. Cancer Genet Cytogenet 20:191-201.
33. Tiainen M, Tammilehto L, Mattson K, Knuutila S (1988): Nonrandom chromosomal abnormalities in malignant pleural mesothelioma. Cancer Genet Cytogenet 33:251-274.
34. Hagemeijer A, Versnal MA, van Drunen E, Meset M, Bouts MJ, van der Kwast TH, Hoogstedan HC (1990): Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet 47:1-28.
35. Frierson HL, Mills SE, Legier JL (1988): Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma. Am J Clin Pathol 90:246-243.
36. Burmer GC, Rabinovitch PS, Kulender BG, Rusch V, McNutt NA (1989): Flow cytometric analysis of malignant pleural mesotheliomas. Hum Pathol 20:777-783.
37. Dazzi H, Thatcher N, Hasleton PS, Chatterjee AK, Lawson RA (1990): DNA analysis by flow cytometry in malignant pleural mesothelioma: Relationship to histology and survival. J Pathol 162:51-55.
38. Pyrhönen S, Laasonen A, Tammilehto L, Rautonen J, Anttila S, Mattson K, Holsti LR (1991): Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma. Eur J Cancer 27:197-200.
39. Dazzi H, Thatcher N, Hasliton PS, Chatterjee AK, Lawson RAM (1990): DNA analysis by flow cytometry in malignant pleural mesothelioma: Relationship to histology and survival. J Pathol 162:51-55.
40. Tiainen M, Rautonen J, Pyrhönen S, Tammilehto L, Mattson K, Knuutila S (1992): Chromosome number correlates with survival in patients with malignant pleural mesothelioma. Cancer Genet Cytogenet 62:21-24.
41. Lechner JF, Tokiwa T, LaVeck M, Benedict WF, Banks-Schlegel S, Yeager H, Banerjee A, Harris CC (1985): Asbesto-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci USA 82:3384-3888.
42. Olofsson K, Mark J (1989): Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells. Cancer Genet Cytogenet 41:33-39.
43. Tammilehto L, Tuomi T, Tiainen M, Rautonen J, Knuutila S, Pyrhönen S, Mattson K (1992): Malignant mesothelioma: Clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients. Eur J Cancer 28A:1373-1379.
44. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K, Knuutila S (1989): Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60:618-626.
45. Gibas Z, Frederick PL, Antman KH, Jernal S, Stahel R, Sarberg AA (1986): Chromosome changes in malignant mesothelioma. Cancer Genet Cytogenet 20:191-201.
46. Melani AM, Stephenson CF, Li FP, Sandberg AA (1992): del (6q) as a possible primary change in malignant mesothelioma. Cancer Genet Cytogenet 59:57-61.
47. Mark J (1978): Monosomy 14, monosomy 22 and 13q: Three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques. Acta Cytol 22:398-401.
48. Taguchi T, Zhou JY, Jhanwar SC, Siegfried JM, Tartof KD, Keller SM, Testa JR (1992): Recurrent chromosome losses in human malignant mesothelioma. Proc Am Assoc Cancer Res 33:40.
49. Popescu NC, Chahinian AP, DiPaolo JA (1988): Nonrandom chromosome alterations in human malignant mesothelioma. Cancer Res 48:142-147.
50. Flejter WL, Li FP, Antman KH, Testa JR (1989): Recurring loss involving chromosomes 1, 3, and 22 in malignant mesothelioma: Possible sites of tumor suppressor genes. Genes Chromosomes Cancer 1:148-154.
51. Hagemeijer A, Versnel MA, van Drunen E, Moret M, Bouts MJ, van der Kwast TH, Hoogsteden HC (1990): Cytogenetic analysis of malignant mesothelioma. Cancer Genet Cytogenet 47:1-28.
52. Tiainen M, Hopman A, Moesker O, Ramaekers F, Wessman M, Laasonen A, Pyrhönen S, Tammilehto L, Mattson K, Knuutila S (1992): Interphase cytogenetics on paraffin sections of malignant pleural mesothelioma. Cancer Genet Cytogenet 62:171-179.
53. Tiainen M, Kere J, Tammilehto L, Mattson K, Knuutila S (1992): Abnormalities of chromosomes 7 and 22 in human malignant pleural mesothelioma: Correlation between Southern blot and cytogenetic analyses. Genes Chromosomes Cancer 4:176-182.
54. Dlahi A, Gerdes H, Chen Q, Saad A, Jhanwar SC (1992): Abnormalities of chromosome 17 and p53 locus in malignant mesothelioma. Proc Am Assoc Cancer Res 33:381.
55. Chang K, Ding IYF, Chang X, Ding YD, Blair O, Kern FG, Willingham MC (1992): Heterogeneous expression of p53 is a common feature of human malignant mesothelioma. Proc Am Assoc Cancer Res 33:382.
56. Kafiri G, Thomas DM, Shepherd NA, Krausz T, Lane DP, Hall PA (1992): p53 expression is common in malignant mesothelioma. Histopathology 21:331-334.
57. Metcalf RA, Welsh JA, Bennett WP, Seddon MB, Lehman TA, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Gerwin BI, Harris CC (1992): p53 and Kirstein-ras mutations in human mesothelioma cell lines. Cancer Res 52:2610-2615.
58. Cote RJ, Jhanwar SC, Movick S, Pellicer A (1991): Genetic alterations of the p53 gene are a feature of malignant mesotheliomas. Cancer Res 51:5410-5416.
59. Cora E, Kane A (1991): Expression of the tumor suppressor gene, p53, during the development of marine malignant mesotheliomas induced by asbestos fibers. FASEB J 5:A1442.
60. van der Meeren A, Kispert J, Seddon MB, Linnainmaa K, Mattson K, Gerwin BI (1993): Retinoblastoma gene expression in human mesothelioma cell lines. Eur Respir Rev (in press).
61. Foulke RS, Davidson K, Zaloznik AJ, Von Hoff D (1991): Absence of oncogene amplification in malignant mesothelioma specimens. Proc ASCO 10:302.
62. Silver BJ (1992): Platelet-derived growth factor in human malignancy. Biofactors 3:217-227.
63. Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, Harris CC (1987): Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines. Cancer Res 47:6180-6184.
64. Versnel MA, Claesson-Welsh L, Hammacher A, et al: Human malignant mesothelioma cell lines express PDGF β receptors whereas cultured normal mesothelial cells express predominantly PDGF α-receptors. Oncogene 1991: 6:2005-2011.
65. Christmas TI, Manning LS, Mustsaers S, Garlepp AJ, Robinson BWS (1993): The role of platelet derived growth factor in the growth of human malignant mesothelioma (MM). Eur Respir Rev (in press)
66. Walker C, Bermudez E, Stewart W, Bonner J, Molloy CJ, Everitt J (1992): Characterization of platelet-derived growth factor and platelet-derived growth factor receptor expression in asbestor-induced rat mesothelioma. Cancer Res 52:301-306.
67. Lee TC, Jagirdar J, Guillemen B, Zhang Y, Rom WN (1992): Insulin-like growth factor gene expression by normal and malignant human mesotheleal cells. Am Rev Respir Dis 145:A124.
68. Higashihara M, Sunaga S, Tange T, Oohashi H, Kurokawa K (1992): Increased secretion of interleukin-6 in malignant mesothelioma cells from a patient with marked thrombocytosis. Cancer 70:2105-2108.
69. Schmitter D, Lauber B, Fagg B, Stahel RA (1992): Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin-6 production as a common feature. Intl J Cancer 51:296-301.
70. Demetri GD, Zenzie BW, Rheinwald JG, Griffin JD (1989): Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro. Blood 74:940-946.
71. Lauber B, Leuthold M, Schmitter D, Cano-Santos J, Waibel R, Stahel RA (1992): An autocrine mitogenic activity produced by a pleural human mesothelioma cell line. Intl J Cancer 50:943-950.
72. Collodi P, Rawson C, Barnes D (1991): Serum free media. In Masters JRW (ed): "Human Cancer in Primary Culture." Dordrecht, The Netherlands: Kleuver Academie Publishers, pp 29-54.
73. Band V, Sager R (1989): Distinctive trais of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long term growth of both cell types. Proc Natl Acad Sci USA 86:1249-1553.
74. Sterner G, Olofsson K, Marsson T, Hagnias B, Merk J (1985): Chromosomes and chromosomal evolution in human mesotheliomas as reflected in sequential analyses of two cases. Hereditas 105:233-239.